Allergy Immunotherapy Market Size, Share & Industry Analysis, By Type (Subcutaneous Immunotherapy, and Sublingual Immunotherapy), By Application (Allergic Rhinitis, Allergic Asthma, and Others), By Distribution Channel (Hospital Pharmacies, and Retail Pharmacies & Online Pharmacies), and Regional Forecast, 2024-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 10.3% from 2024-2032

Unit

Value (USD billion)

Segmentation

By Type

• Subcutaneous Immunotherapy
• Sublingual Immunotherapy

By Application

• Allergic Rhinitis
• Allergic Asthma
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies & Online Pharmacies

By Geography

• North America (By Type, By Application, By Distribution Channel, By Country)
  • U.S.
  • Canada
• Europe (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Poland
  • Sweden
  • Norway
  • Denmark
  • Rest of Europe
• Asia Pacific (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa